Xenon Pharmaceuticals (XENE) Misses Q1 EPS by 1c
Get Alerts XENE Hot Sheet
Join SI Premium – FREE
Xenon Pharmaceuticals (NASDAQ: XENE) reported Q1 EPS of ($0.63), $0.01 worse than the analyst estimate of ($0.62).
For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
- General Mills (GIS) Tops Q1 EPS by 3c
- Unity Bancorp CEO to retire in 2027, president to take over
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share